67 related articles for article (PubMed ID: 8804141)
1. Robust Bayesian approaches for clinical trial monitoring.
Carlin BP; Sargent DJ
Stat Med; 1996 Jun; 15(11):1093-106. PubMed ID: 8804141
[TBL] [Abstract][Full Text] [Related]
2. Approaches for optimal sequential decision analysis in clinical trials.
Carlin BP; Kadane JB; Gelfand AE
Biometrics; 1998 Sep; 54(3):964-75. PubMed ID: 9750245
[TBL] [Abstract][Full Text] [Related]
3. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
[TBL] [Abstract][Full Text] [Related]
4. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
5. [Meta-analysis of the Italian studies on short-term effects of air pollution].
Biggeri A; Bellini P; Terracini B;
Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
[TBL] [Abstract][Full Text] [Related]
6. Bayesian design of single-arm phase II clinical trials with continuous monitoring.
Johnson VE; Cook JD
Clin Trials; 2009 Jun; 6(3):217-26. PubMed ID: 19528131
[TBL] [Abstract][Full Text] [Related]
7. Predictive checking for Bayesian interim analyses in clinical trials.
Daimon T
Contemp Clin Trials; 2008 Sep; 29(5):740-50. PubMed ID: 18571477
[TBL] [Abstract][Full Text] [Related]
8. Use of a Bayesian approach to decide when to stop a therapeutic trial: the case of a chemoprophylaxis trial in human immunodeficiency virus infection.
Kpozèhouen A; Alioum A; Anglaret X; Van de Perre P; Chêne G; Salamon R
Am J Epidemiol; 2005 Mar; 161(6):595-603. PubMed ID: 15746476
[TBL] [Abstract][Full Text] [Related]
9. Sample size reestimation by Bayesian prediction.
Wang MD
Biom J; 2007 Jun; 49(3):365-77. PubMed ID: 17623342
[TBL] [Abstract][Full Text] [Related]
10. Quantifying and documenting prior beliefs in clinical trials.
Chaloner K; Rhame FS
Stat Med; 2001 Feb; 20(4):581-600. PubMed ID: 11223902
[TBL] [Abstract][Full Text] [Related]
11. Bayesian predictive approach to interim monitoring in clinical trials.
Dmitrienko A; Wang MD
Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
[TBL] [Abstract][Full Text] [Related]
12. Assessing the success probability of a Phase III clinical trial based on Phase II data.
Su Z
Contemp Clin Trials; 2010 Nov; 31(6):620-3. PubMed ID: 20713180
[TBL] [Abstract][Full Text] [Related]
13. Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.
Chêne G; Morlat P; Leport C; Hafner R; Dequae L; Charreau I; Aboulker JP; Luft B; Aubertin J; Vildé JL; Salamon R
Control Clin Trials; 1998 Jun; 19(3):233-48. PubMed ID: 9620807
[TBL] [Abstract][Full Text] [Related]
14. Bayesian evaluation of group sequential clinical trial designs.
Emerson SS; Kittelson JM; Gillen DL
Stat Med; 2007 Mar; 26(7):1431-49. PubMed ID: 17066402
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of pyrimethamine in monotherapy for preventing toxoplasmosis in AIDS].
De Truchis P; Flament-Saillour M; Risbourg M; Urtizberea JA; Dournon E
Presse Med; 1996 Jul 6-13; 25(24):1125. PubMed ID: 8868957
[No Abstract] [Full Text] [Related]
16. Bayesian clinical trials.
Berry DA
Nat Rev Drug Discov; 2006 Jan; 5(1):27-36. PubMed ID: 16485344
[TBL] [Abstract][Full Text] [Related]
17. A Bayesian analysis of pharmacoeconomic data from a clinical trial on schizophrenia.
Petit C; Maccario J
Stat Med; 2003 Mar; 22(6):1025-39. PubMed ID: 12627416
[TBL] [Abstract][Full Text] [Related]
18. An illustration of the modelling of cost and efficacy data from a clinical trial.
Hahn S; Whitehead A
Stat Med; 2003 Mar; 22(6):1009-24. PubMed ID: 12627415
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
[TBL] [Abstract][Full Text] [Related]
20. Bayesian analysis for generalized linear models with nonignorably missing covariates.
Huang L; Chen MH; Ibrahim JG
Biometrics; 2005 Sep; 61(3):767-80. PubMed ID: 16135028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
